Benzodiazepines with prescription rate <1 per 1000 consultations, Australian general practices, 2011–2018 (N = 55 903 294 consultations)a
| Medication | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | Annual change, % (95% CI) |
|---|---|---|---|---|---|---|---|---|---|
| Lorazepam | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | 0.9 | 1.0 | 6.4 (4.5 to 8.3) |
| Clonazepam | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 (−0.5 to 1.9) |
| Flunitrazepam | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | −13.2 (−16.0 to −10.4) |
| Bromazepam | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | −4.9 (−7.6 to −2.2) |
| Clobazam | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 2.6 (−0.1 to 5.3) |
| Midazolam | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 51.8 (40.9 to 63.5) |
↵a Results adjusted for age and sex. CI = confidence interval.